Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
16.50
Oct 28 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
409.86M
Enterprise Value
447.20M
Income
-43.08M
Sales
75.63M
Book/sh
-0.90
Cash/sh
0.45
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
226
IPO
Mar 29, 2012
P/E
-
Forward P/E
-
PEG
-
P/S
5.42
P/B
-
P/C
36.79
P/FCF
-
EV/EBITDA
-
EV/Sales
5.91
Quick Ratio
0.34
Current Ratio
0.41
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-1.44
EPS next Y
-0.38
EPS next Q
-0.24
EPS this Y
45.66%
EPS next Y
59.31%
EPS next 5Y
-
EPS past 3/5Y
-17.81% 3.38%
Sales past 3/5Y
27.66% 38.09%
EPS Y/Y TTM
26.76%
Sales Y/Y TTM
1.00%
EPS Q/Q
33.76%
Sales Q/Q
17.83%
Insider Own
1.93%
Insider Trans
11.44%
Inst Own
20.04%
Inst Trans
-2.60%
ROA
-81.36%
ROE
-1746.27%
ROIC
-
Gross Margin
81.56%
Oper. Margin
-46.57%
Profit Margin
-56.96%
SMA20
18.81%
SMA50
37.86%
SMA200
156.83%
Trades
Shs Outstand
30.93M
Shs Float
24.36M
52W High
16.68 -1.08%
52W Low
3.22 412.42%
Volatility
6.35% 6.21%
ATR (14)
0.84
RSI (14)
79.57
Beta
2.10
Rel Volume
0.00
Avg Volume
473.31K
Volume
0
Perf Week
7.91%
Perf Month
37.96%
Perf Quarter
267.48%
Perf Half Y
290.07%
Perf YTD
378.26%
Perf Year
350.82%
Perf 3Y
77.61%
Perf 5Y
-0.42%
Perf 10Y
64.18%
Prev Close
16.50
Price
16.50
Change %
0.00%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woody Joseph FralinDirectorJun 09 '26Buy4.005,20020,800107,961Jun 10 09:17 PM
Woody Joseph FralinDirectorJun 09 '26Buy4.1910,00041,900102,761Jun 09 04:58 PM
Woody Joseph FralinDirectorJun 03 '26Buy4.0910,00040,94992,761Jun 05 05:00 PM
Woody Joseph FralinDirectorJun 01 '26Buy4.3010,00043,00010,000Jun 03 04:30 PM
Woody Joseph FralinDirectorJun 02 '26Buy4.1910,00041,93620,000Jun 03 04:30 PM
O'Toole David DCFOMay 20 '26Buy4.262,0008,520145,927May 20 04:30 PM
O'Toole David DCFOMay 19 '26Buy4.242,0008,480143,927May 19 04:30 PM
O'Toole David DCFOFeb 19 '26Buy4.153,00012,450140,127Feb 23 04:30 PM
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
PresidentMr. Cary G. Vance
Chief Financial OfficerMr. David O'Toole
Chief Legal & Compliance Officer & Corporate SecretaryMs. Nicole Linda Kelsey
P.M.P.Dr. Niraj Doshi J.D.
Senior Vice President of Scientific & Medical AffairsDr. Katie Bush Ph.D.